-- China's tax regulator imposed a fine of 46.1 million yuan on Huapont Life Sciences' (SHE:002004) subsidiary, Shenyang Xinma Pharmaceutical, for overdue tax payments, according to a Wednesday disclosure on the Shenzhen bourse.
The period of the penalties was from between Jan. 1, 2019, and Dec. 31, 2024.
The pesticide chemical product manufacturer's shares fell by less than 2% at the close.